Reata Pharmaceuticals Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 323

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $6.89B

Reata Pharmaceuticals General Information

Description

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.

Contact Information

Formerly Known As
Reata Discovery
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Corporate Office
  • 5320 Legacy Drive
  • Plano, TX 75024
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reata Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Merger/Acquisition 26-Sep-2023 $6.89B 00.000 00.000 Completed Generating Revenue/Not Profitable
14. Debt - General 01-May-2023 00000 00.000 Completed Generating Revenue/Not Profitable
13. PIPE 24-Jun-2020 0000 00.000 Completed Generating Revenue
12. 2PO 14-Nov-2019 00000 00.000 Completed Generating Revenue
11. 2PO 06-Dec-2016 000.00 Cancelled Generating Revenue
10. Debt - General 03-Apr-2017 0000 00000 Completed Generating Revenue
9. IPO 26-May-2016 000.00 00000 00000 Completed Generating Revenue
8. Later Stage VC (Series H) 13-Jul-2011 00000 00000 000 Completed Generating Revenue
7. Later Stage VC (Series G) 28-Sep-2009 $78M $176M 00000 Completed Generating Revenue
6. Later Stage VC (Series F) 04-Dec-2008 $32M $98.4M 00000 Completed Generating Revenue
To view Reata Pharmaceuticals’s complete valuation and funding history, request access »

Reata Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series H 0,000,000 00.000000 00.00 000.00 000.00 00 000.00 000
Series G2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series G1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series F 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series C 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00
Series B 3,331,247 $0.001000 $0.12 $1.5 $1.5 1x $1.5 3.4%
Series A 1,751,000 $0.001000 $0.08 $1 $1 1x $1 1.79%
To view Reata Pharmaceuticals’s complete cap table history, request access »

Reata Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commerci
Drug Discovery
Plano, TX
323 As of 2022
00.000
00.000 0000-00-00
000000&0 00.000

000000

modo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse c
0000 000000000
San Diego, CA
000 As of 0000
00000
000000000 00000

000000

sectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore m
000000000000000
Lexington, MA
000 As of 0000
00000
00000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Reata Pharmaceuticals Competitors (84)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Crinetics Pharmaceuticals Formerly VC-backed San Diego, CA 000 00000 000000000 00000
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA 000 00000 000000&0 00000
Strongbridge Biopharma Corporate Backed or Acquired Trevose, PA 00 00000 000000&0 00000
Amunix Pharmaceuticals Formerly PE-Backed South San Francisco, CA 00 00000 000000&0 00000
Gilead Sciences Formerly VC-backed Foster City, CA 00000 000.00 0000
You’re viewing 5 of 84 competitors. Get the full list »

Reata Pharmaceuticals Executive Team (22)

Name Title Board Seat Contact Info
Seemi Khan Chief Medical Officer & Senior Vice President
You’re viewing 1 of 22 executive team members. Get the full list »

Reata Pharmaceuticals Board Members (10)

Name Representing Role Since
Martin Edwards MD Self Board Member 000 0000
R. Kent McGaughy Jr. CPMG Board Member 000 0000
Shamim Ruff Reata Pharmaceuticals Board Member 000 0000
Steven Ryder MD Self Board Member 000 0000
William McClellan Jr. Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Reata Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reata Pharmaceuticals Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AbbVie Corporation Majority 000 0000 000000 0
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Blackstone PE/Buyout Minority 000 0000 000000 0
CIC Partners PE/Buyout Minority 000 0000 000000 0
CPMG Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Reata Pharmaceuticals FAQs

  • When was Reata Pharmaceuticals founded?

    Reata Pharmaceuticals was founded in 2002.

  • Who is the founder of Reata Pharmaceuticals?

    Warren Huff JD is the founder of Reata Pharmaceuticals.

  • Where is Reata Pharmaceuticals headquartered?

    Reata Pharmaceuticals is headquartered in Plano, TX.

  • What is the size of Reata Pharmaceuticals?

    Reata Pharmaceuticals has 323 total employees.

  • What industry is Reata Pharmaceuticals in?

    Reata Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Reata Pharmaceuticals a private or public company?

    Reata Pharmaceuticals is a Private company.

  • What is the current valuation of Reata Pharmaceuticals?

    The current valuation of Reata Pharmaceuticals is 00.000.

  • What is Reata Pharmaceuticals’s current revenue?

    The current revenue for Reata Pharmaceuticals is 000000.

  • How much funding has Reata Pharmaceuticals raised over time?

    Reata Pharmaceuticals has raised $1.34B.

  • Who are Reata Pharmaceuticals’s investors?

    AbbVie, AbbVie Ventures, Blackstone, CIC Partners, and CPMG are 5 of 14 investors who have invested in Reata Pharmaceuticals.

  • Who are Reata Pharmaceuticals’s competitors?

    Crinetics Pharmaceuticals, Dicerna Pharmaceuticals, Strongbridge Biopharma, Amunix Pharmaceuticals, and Gilead Sciences are some of the 84 competitors of Reata Pharmaceuticals.

  • When was Reata Pharmaceuticals acquired?

    Reata Pharmaceuticals was acquired on 26-Sep-2023.

  • Who acquired Reata Pharmaceuticals?

    Reata Pharmaceuticals was acquired by Biogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »